Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 1/20 | 0.45 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.45 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 5/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 2/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | LTA4H | P09960 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10240 | 0.90 | THRB (0.41) | TSHRCA1CA2THRB | |
| SCHEMBL6909601 | 0.88 | THRB (0.47) | TSHRCA1CA2THRB | |
| SCHEMBL14688826 | 0.88 | THRB (0.47) | TSHRCA1CA2THRB | |
| SCHEMBL1149381 | 0.88 | THRB (0.47) | TSHRCA1CA2THRB | |
| SCHEMBL187269 | 0.88 | THRB (0.47) | TSHRCA1CA2THRB | |
| SCHEMBL21581247 | 0.88 | THRB (0.47) | TSHRCA1CA2THRB | |
| SCHEMBL493840 | 0.88 | THRB (0.47) | TSHRCA1CA2THRB | |
| SCHEMBL3332706 | 0.88 | THRB (0.47) | TSHRCA1CA2THRB | |
| SCHEMBL9221661 | 0.88 | THRB (0.47) | TSHRCA1CA2THRB | |
| SCHEMBL911135 | 0.88 | THRB (0.47) | TSHRCA1CA2THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1413 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12597611-B2 | Cathode for an electrochemical cell including at least one cathode additive | DURACELL U.S. OPERATIONS, INC. (US) | 2026-04-07 | — | — | US | claimed |
| US-20250194617-A1 | Materials and Methods for Extending Shelf-Life of Foods | JP LABORATORIES, INC. | 2025-06-19 | — | — | US | claimed |
| CN-119978389-A | Boron-containing oligomer for aging-resistant high-transparency addition-type silicon rubber, and preparation method and application thereof | 中国科学院化学研究所 | 2025-05-13 | — | — | CN | claimed |
| EP-4288413-B1 | PROCESS FOR THE PREPARATION OF A NITRIC OXIDE DONATING PROSTAGLANDIN ANALOGUE | NICOX SA (FR) | 2025-01-22 | — | — | EP | claimed |
| US-20240158345-A1 | PROCESS FOR THE PREPARATION OF A NITRIC OXIDE DONATING PROSTAGLANDIN ANALOGUE | NICOX SA (FR) | 2024-05-16 | — | — | US | claimed |
| US-20240092822-A1 | PURIFICATION METHODS FOR OLIGOMERIC COMPOUNDS | IONIS PHARMACEUTICALS, INC. (US) | 2024-03-21 | — | — | US | claimed |
| EP-4301766-A1 | PURIFICATION METHODS FOR OLIGOMERIC COMPOUNDS | Ionis Pharmaceuticals, Inc. (US) | 2024-01-10 | — | — | EP | claimed |
| EP-4288413-A1 | PROCESS FOR THE PREPARATION OF A NITRIC OXIDE DONATING PROSTAGLANDIN ANALOGUE | Nicox S.A. (FR) | 2023-12-13 | — | — | EP | claimed |
| US-20230380457-A1 | Materials and Methods for Extending Shelf-Life of Foods | JP LABORATORIES, INC. | 2023-11-30 | — | — | US | claimed |
| EP-4280882-A2 | MATERIALS AND METHODS FOR EXTENDING SHELF-LIFE OF FOODS | JP LABORATORIES, INC. (US) | 2023-11-29 | — | — | EP | claimed |
| US-20030198761-A1 | Ink recording element containing stabilized polymeric particles | EASTMAN KODAK COMPANY | 2003-10-23 | — | — | US | claimed |
| US-6623831-B2 | Ink jet printer that is responsive to digital data signals; loaded with substrate with subbing layer comprising a polymeric binder and a borate and an image-receiving layer comprising particles and a cross-linkable polymer | EASTMAN KODAK COMPANY | 2003-09-23 | — | — | US | claimed |
| US-6623819-B2 | With subbing layer of polymeric binder and borate | EASTMAN KODAK COMPANY | 2003-09-23 | — | — | US | claimed |
| EP-1318026-A2 | Ink jet recording element and printing method | EASTMAN KODAK COMPANY (US) | 2003-06-11 | — | — | EP | claimed |
| US-20030103122-A1 | Ink jet recording element | EASTMAN KODAK COMPANY | 2003-06-05 | — | — | US | claimed |
| US-20030103130-A1 | Ink jet printing method | EASTMAN KODAK COMPANY | 2003-06-05 | — | — | US | claimed |
| US-5955416-A | COMPRISING LIPASES, ANIONIC SURFACTANT SYSTEM, BORATE COMPOUND, AND POLYHYDROXY FATTY ACID AMIDE; PROVIDE IMPROVED GREASY SOIL REMOVAL OVER A WIDE RANGE OF TEMPERATURES | THE PROCTER & GAMBLE COMPANY (US) | 1999-09-21 | — | — | US | claimed |
| WO-1995005081-A1 | BIOCIDAL COMPOSITIONS CONTAINING ORGANOBORON COMPOUNDS | U.S. BORAX INC. (US) | 1995-02-23 | — | — | WO | claimed |
| US-5384410-A | Removal of boronic acid protecting groups by transesterification | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1995-01-24 | — | — | US | claimed |
| US-4339351-A | REACTION PRODUCT OF GRIGNARD REAGENT AND BORON COMPOUND AS CATALYST SUPPORT | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1982-07-13 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12597611-B2 | Cathode for an electrochemical cell including at least one cathode additive | EED, SELE, CTNND1 | ADRB2 4032/4885ADRB1 4248/4885ADRB3 4405/4885 |
| US-20240158345-A1 | PROCESS FOR THE PREPARATION OF A NITRIC OXIDE DONATING PROSTAGLANDIN ANALOGUE | NOS3, NOS2, PTGIS | ADRB2 874/4885ADRB1 1222/4885ADRB3 644/4885 |
| US-20240092822-A1 | PURIFICATION METHODS FOR OLIGOMERIC COMPOUNDS | FBL, C9, DIS3 | ADRB2 4766/4885ADRB1 4675/4885ADRB3 4415/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.